GoConnect Ltd (NSX:GO8) holds 43.5% of Go Green Holdings Ltd which holds a major interest of 24% in COVIRIX Medical. The proposed merger values COVIRIX Medical at US$617 million which, when consummated, will involve NIVF issuing its shares at a deemed price of US$6 per share.
GoConnect Limited (NSX:GO8) advise that COVIRIX Medical and Numolux Group have entered into a strategic partnership for anti-viral drug development platform.
The Directors of GoConnect Limited provide the following report for the quarter ended 30 June 2023. GO8 continued to derive income from sale of investment. Go Green Holdings Ltd co-founded by GO8 is.
GoConnect Limited (NSX:GO8) is pleased to advise that COVIRIX Medical Pty Ltd, of which Go Green Holdings Ltd has a 24% interest, has been granted a 20 years patent by IP Australia for the company s repurposed antiviral treatment and prevention of pulmonary infections.
GoConnect Limited (NSX:GO8) continued to derive income from sale of investment. However, in the June 2022 quarter, GO8 withheld further sale pending the generation of revenue from a number of investments held by Go Green Holdings Ltd.